Subtype
Malignant Intestinal Neoplasm
CI-CAN-00001137Explore in graph →
1,666 active trials21 approved drugs383 evidence items
- NCIt
- C4572
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001137Explore in graph →
Clinical trials
7,771 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (772)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01251237 | Study to Assess the Tolerability, Safety and Efficacy of an Adapted Gut Cleansing Solution in Routine Colon Cleansing Prior to Colonoscopies | completed | Phase 2 | 120 | NorgineINDUSTRY | 1 | Dec 1, 2010 | clinicaltrials |
| NCT00228189 | Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients | completed | Phase 1 / Phase 2 | 30 | Radboud University Medical CenterOTHER | 1 | Nov 30, 2010 | clinicaltrials |
| NCT00784667 | Dual Inhibition of EGFR Signalling Using the Combination of Cetuximab and Erlotinib(Dux) | unknown | Phase 2 | 50 | Austin HealthOTHER_GOV | 1 | Nov 30, 2010 | clinicaltrials |
| NCT01249521 | Dual Targeting of Vascular Endothelial Growth Factor-A Together With Angiopoietins in Chemotherapy-naïve Metastatic Colorectal Cancer(Vengeance) | unknown | Phase 2 | 40 | Austin HealthOTHER_GOV | 1 | Nov 30, 2010 | clinicaltrials |
| NCT00386828 | Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial | completed | Phase 2 | 43 | British Columbia Cancer AgencyOTHER | 1 | Nov 25, 2010 | clinicaltrials |
| NCT01144195 | A Clinical Trial of Panitumumab in Combination With FOLFIRI Chemotherapy as Second Line Treatment in Subjects With Metastatic Colorectal Cancer Expressing Wild-type KRAS and Who Had Progressed ≥ 6 Months After the Last Dose of the First Line Chemotherapy(ACTIVE) | unknown | Phase 2 | 80 | Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socialsOTHER | 1 | Nov 10, 2010 | clinicaltrials |
| NCT00254137 | Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer. | completed | Phase 2 | 92 | Ludwig-Maximilians - University of MunichOTHER | 0 | Oct 28, 2010 | clinicaltrials |
| NCT01212718 | Response Prediction in Metastasized Colorectal Cancer Using Intratumoral Thymidylate Synthase(FOGT5) | completed | Phase 2 | 168 | University of UlmOTHER | 1 | Oct 1, 2010 | clinicaltrials |
| NCT01193452 | S-1/Leucovorin (SL) Versus sLV5FU2 as the First-line Treatment for Elderly Patients With Colorectal Cancer | unknown | Phase 2 | 100 | Fudan UniversityOTHER | 1 | Sep 2, 2010 | clinicaltrials |
| NCT00102024 | Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma | terminated | Phase 1 / Phase 2 | 30 | BiogenINDUSTRY | 1 | Aug 27, 2010 | clinicaltrials |
| NCT00345761 | Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer | completed | Phase 1 / Phase 2 | 64 | Chugai PharmaceuticalINDUSTRY | 1 | Aug 16, 2010 | clinicaltrials |
| NCT01177371 | High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma | completed | Phase 2 | 13 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00172159 | Influence of Neoadjuvant Therapy on the Resectability of Hepatic Metastases From Colorectal Cancers | unknown | Phase 2 | 100 | National Taiwan University HospitalOTHER | 1 | Jun 23, 2010 | clinicaltrials |
| NCT01142713 | The Impact of Patient Positioning and Use of Belly Board on Small Bowel and Urinary Bladder Volume Irradiated in Patients Receiving Radiotherapy for Rectal Cancer: A Prospective Phase II Study | unknown | Phase 2 | 30 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00005981 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 13 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 10, 2010 | clinicaltrials |
| NCT00671996 | Mangafodipir as an Adjunct to FOLFOX6 Chemotherapy in Colon Cancer Stage Dukes' C(MANFOL) | completed | Phase 2 | 14 | Egetis TherapeuticsINDUSTRY | 1 | May 4, 2010 | clinicaltrials |
| NCT01024504 | Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 46 | Hellenic Oncology Research GroupOTHER | 1 | Apr 9, 2010 | clinicaltrials |
| NCT00005804 | Bone Marrow Transplantation in Treating Patients With Hematologic Cancer | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 2, 2010 | clinicaltrials |
| NCT00948337 | A Study With Health Educational Material on Health Promotion in Cancer Survivors | unknown | Phase 2 | 326 | National Cancer Center, KoreaOTHER_GOV | 1 | Feb 26, 2010 | clinicaltrials |
| NCT00277303 | Study of XL999 in Patients With Metastatic Colorectal Cancer | terminated | Phase 2 | 17 | Symphony Evolution, Inc.INDUSTRY | 1 | Feb 22, 2010 | clinicaltrials |
| NCT00274872 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | unknown | Phase 2 / Phase 3 | 600 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Feb 1, 2010 | clinicaltrials |
| NCT00251186 | First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients | terminated | Phase 2 | 18 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Jan 26, 2010 | clinicaltrials |
| NCT00285701 | Early Detection of Polyps and Colon Cancer by Fluorescence Imaging - a Dose-finding Study | completed | Phase 1 / Phase 2 | 38 | PhotocureINDUSTRY | 1 | Jan 15, 2010 | clinicaltrials |
| NCT00383695 | Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal Cancer(EXPERT-C) | unknown | Phase 2 | 164 | Royal Marsden NHS Foundation TrustOTHER | 3 | Jan 13, 2010 | clinicaltrials |
| NCT00220116 | Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer | completed | Phase 2 | 172 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jan 6, 2010 | clinicaltrials |
| NCT00677287 | Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer | terminated | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00677612 | Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer | terminated | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00220155 | Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal Cancer | completed | Phase 2 | 16 | Royal Marsden NHS Foundation TrustOTHER | 1 | Dec 16, 2009 | clinicaltrials |
| NCT00020930 | Cetuximab in Treating Patients With Stage IV Colorectal Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 4, 2009 | clinicaltrials |
| NCT00165568 | Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer | completed | Phase 2 | 20 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
| NCT00997685 | Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC) | unknown | Phase 2 | 110 | Guangdong Provincial People's HospitalOTHER | 1 | Oct 19, 2009 | clinicaltrials |
| NCT00399750 | TREE-2: Three Regimens of Eloxatin in Advanced Colorectal Cancer | completed | Phase 2 | 373 | SanofiINDUSTRY | 1 | Oct 15, 2009 | clinicaltrials |
| NCT00625573 | Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01)(ABX067) | completed | Phase 2 | 29 | Mt. Sinai Medical Center, MiamiOTHER | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00853684 | Oxaliplatin, Capecitabine and Endostar as First Line Treatment for Patients With Advanced Colorectal Cancer(OXCE) | unknown | Phase 2 | 44 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00327119 | Phase 2 Study of ABX-EGF (Panitumumab) in Japanese Subjects With M-colorectal Cancer | completed | Phase 2 | 50 | AmgenINDUSTRY | 0 | Sep 14, 2009 | clinicaltrials |
| NCT00972465 | Study of Nimotuzumab to Treat Colorectal Cancer | unknown | Phase 2 | 48 | Peking UniversityOTHER | 1 | Sep 7, 2009 | clinicaltrials |
| NCT00964457 | Treatment of Patients With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before, Under and After Radiation and With Adding Cetuximab to K-RAS Wild-type Patients | unknown | Phase 2 | 60 | Copenhagen University Hospital at HerlevOTHER | 1 | Aug 25, 2009 | clinicaltrials |
| NCT00496704 | Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan | unknown | Phase 1 / Phase 2 | 56 | Yonsei UniversityOTHER | 1 | Aug 21, 2009 | clinicaltrials |
| NCT00513266 | Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery | unknown | Phase 2 | 35 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Aug 7, 2009 | clinicaltrials |
| NCT00107861 | Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases | completed | Phase 1 / Phase 2 | 44 | BiogenINDUSTRY | 1 | Jul 14, 2009 | clinicaltrials |
| NCT00936572 | Probiotics In Colorectal Cancer Patients | completed | Phase 2 | 35 | University of Milano BicoccaOTHER | 1 | Jul 10, 2009 | clinicaltrials |
| NCT00884767 | Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin | unknown | Phase 2 | 206 | Institut Cancerologie de l'OuestOTHER | 1 | Jul 8, 2009 | clinicaltrials |
| NCT00498407 | A Phase II Study of CP-4055 as Second Line Therapy in Patients With Advanced Colorectal Cancer | completed | Phase 2 | 16 | Clavis PharmaINDUSTRY | 1 | Jun 4, 2009 | clinicaltrials |
| NCT00854971 | Efficacy Study of TKcell in Advanced Colorectal Cancer | unknown | Phase 1 / Phase 2 | 86 | BinexINDUSTRY | 1 | May 18, 2009 | clinicaltrials |
| NCT00890188 | Thalidomide and Tegafur/Uracil(UFUR) in the Treatment of Advanced Colorectal Cancer(UFUR) | unknown | Phase 2 | 34 | National Cheng-Kung University HospitalOTHER | 1 | May 7, 2009 | clinicaltrials |
| NCT00123851 | Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00242788 | IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure | completed | Phase 1 / Phase 2 | 40 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00254683 | Use of Positron Emission Tomography/Computed Tomography (PET/CT) to Assess Tumor Response to Neoadjuvant Treatment for Distal Rectal Cancer | unknown | Phase 2 | 100 | University of Sao PauloOTHER | 1 | Apr 14, 2009 | clinicaltrials |
| NCT00153998 | Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM) | completed | Phase 2 | 135 | Technische Universität DresdenOTHER | 2 | Feb 27, 2009 | clinicaltrials |
| NCT00422773 | Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan in First-Line Treatment of Metastatic Colorectal Cancer | completed | Phase 1 / Phase 2 | 21 | Technische Universität DresdenOTHER | 1 | Feb 27, 2009 | clinicaltrials |
Data updated 22 days agoSource updated Dec 1, 2010source: clinicaltrials